Ustekinumab Maintained Clinically Meaningful Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease: Results From the IM-UNITI Long-Term Extension

被引：0
|
作者：
Sands, Bruce E. [1 ]
Han, Chenglong [2 ]
Gasink, Christopher [3 ]
Bin, Zou [4 ]
Stephen, Targan [5 ]
Sandborn, William J. [6 ]
Feagan, Brian G. [7 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Janssen Global Serv LLC, Malvern, PA USA
[3] Janssen Sci Affairs LLC, Horsham, PA USA
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
[7] Robarts Clin Trials, London, ON, Canada
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
690
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [1] Long-term (5-year) maintenance of clinically meaningful improvement in health-related quality of life in patients with moderate to severe Crohn's disease treated with ustekinumab in the IM-UNITI long-term extension study
    Sandborn, William J.
    Ghosh, Subrata
    Han, Chenglong
    Gasink, Christopher
    Zou, Bin
    Feagan, Brian G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 108 - 109
  • [2] LONG-TERM (5-YEAR) MAINTENANCE OF CLINICALLY MEANINGFUL IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE TREATED WITH USTEKINUMAB IN THE IM-UNITI LONG-TERM EXTENSION STUDY
    Sandborn, William J.
    Ghosh, Subrata
    Han, Chenglong
    Gasink, Christopher
    Zou, Bin
    Feagan, Brian G.
    GASTROENTEROLOGY, 2021, 160 (06) : S558 - S559
  • [3] USTEKINUMAB MAINTAINED CLINICALLY MEANINGFUL IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI LONG-TERM EXTENSION
    Sandborn, William J.
    Rowbotham, David
    Leong, Rupert W.
    Han, Chenglong
    Zhou, Yiying
    Zhang, Hongyan
    Johanns, Jewel
    Marano, Colleen W.
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S433 - S433
  • [4] Ustekinumab maintained clinically meaningful improvement in health-related quality of life in patients with moderate to severe ulcerative colitis: Results from the UNIFI long-term extension
    Sandborn, W. J.
    Rowbotham, D. S.
    Leong, R. W. L.
    Han, C.
    Zhou, Y.
    Zhang, H.
    Johanns, J.
    Marano, C.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S094 - S095
  • [5] Efficacy and Safety of Ustekinumab for Crohn's Disease: Results From IM-UNITI Long-Term Extension Through 3 Years
    Sandborn, William J.
    Rutgeerts, Paul
    Jacobstein, Douglas
    Gasink, Christopher
    Patel, Reese
    Zou, Bin
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem
    Colombel, Jean-Frederic
    Feagan, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S345 - S346
  • [6] LONG TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH 2 YEARS
    Sandborn, W. J.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L.
    Johanns, J.
    Sands, B.
    Hanauer, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. F.
    Feagan, B. G.
    GUT, 2017, 66 : A22 - A22
  • [7] LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH TWO YEARS
    Sandborn, William J.
    Rutgeerts, Paul
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan R.
    Ghosh, Subrata
    de Villiers, Willem J.
    Colombel, Jean Frederic
    Feagan, Brian G.
    GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [8] Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
    Sandborn, W.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L. -L.
    Johanns, J.
    Sands, B.
    Hanauer, S. B.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. -F.
    Feagan, B. G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S6 - S6
  • [9] IMMUNOGENICITY OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Nussbaum, Jeannette
    Oortwijn, Alessandra
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Adedokun, Omoniyi J.
    de Villiers, Willem J.
    Ghosh, Subrata
    GASTROENTEROLOGY, 2019, 156 (06) : S1097 - S1097
  • [10] Efficacy and Safety of Ustekinumab for Crohn's Disease Through 5 Years: Final Results From the IM-UNITI Long-Term Extension
    Sandborn, William J.
    Rutgeerts, Paul
    Lynch, John
    Rebuck, Rory
    Wang, Yuhua
    Zou, Bin
    Gasink, Christopher
    Adedokun, Omoniyi
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem J. S.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S324
12345